Silexion Therapeutics Ltd. (SLXN)

NASDAQ·Healthcare·Biotechnology

$2.97

+9.23%

Mkt Cap $1.10M

No analyst coverage available

We don't have analyst ratings or price target data for Silexion Therapeutics Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.